Search for other papers by Charlotte Höybye in
Google Scholar
PubMed
Search for other papers by Beverly M K Biller in
Google Scholar
PubMed
Search for other papers by Jean-Marc Ferran in
Google Scholar
PubMed
Search for other papers by Murray B Gordon in
Google Scholar
PubMed
Search for other papers by Nicky Kelepouris in
Google Scholar
PubMed
Search for other papers by Navid Nedjatian in
Google Scholar
PubMed
Search for other papers by Anne H Olsen in
Google Scholar
PubMed
Search for other papers by Matthias M Weber in
Google Scholar
PubMed
for AGHD (GH treated) who were enrolled in two non-interventional, multicentre studies: the NordiNet ® International Outcome Study (IOS) and the American Norditropin ® Studies: Web-Enabled Research (ANSWER) Program ( 16 , 17 ). The CV risks of
Search for other papers by Robert Rapaport in
Google Scholar
PubMed
Search for other papers by Peter A Lee in
Google Scholar
PubMed
Nemours/DuPont Hospital for Children, Wilmington, Delaware, USA
Search for other papers by Judith L Ross in
Google Scholar
PubMed
Search for other papers by Paul Saenger in
Google Scholar
PubMed
Search for other papers by Vlady Ostrow in
Google Scholar
PubMed
Search for other papers by Giuseppe Piccoli in
Google Scholar
PubMed
developed as practical tools to estimate the response to GH therapy for the diagnosis of growth hormone deficiency (GHD) ( 19 ), SGA ( 20 ) and ISS ( 21 ). The non-interventional American Norditropin Studies: Web-Enabled Research (ANSWER) Program was
Search for other papers by Dirk-Jan van Beek in
Google Scholar
PubMed
Search for other papers by Rachel S van Leeuwaarde in
Google Scholar
PubMed
Search for other papers by Carolina R C Pieterman in
Google Scholar
PubMed
Search for other papers by Menno R Vriens in
Google Scholar
PubMed
Parelsnoer Institute, Utrecht, The Netherlands
Search for other papers by Gerlof D Valk in
Google Scholar
PubMed
Search for other papers by the DutchMEN Study Group in
Google Scholar
PubMed
designed. The aim was to answer multiple research questions that were based on the clinical dilemmas MEN1 patients and their treating physicians encountered in daily practice. The aim of this project was to provide patients and physicians with valid data
Search for other papers by Alicia Romano in
Google Scholar
PubMed
Search for other papers by Juan Pablo Kaski in
Google Scholar
PubMed
Search for other papers by Jovanna Dahlgren in
Google Scholar
PubMed
Search for other papers by Nicky Kelepouris in
Google Scholar
PubMed
Search for other papers by Alberto Pietropoli in
Google Scholar
PubMed
Search for other papers by Tilman R Rohrer in
Google Scholar
PubMed
Search for other papers by Michel Polak in
Google Scholar
PubMed
observational studies. Materials and methods Study design and ethics The NordiNet® International Outcomes Study (IOS; NCT00960128) and ANSWER Program (NCT01009905) were observational, multicentre studies monitoring the real-world long-term outcomes
Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, the Netherlands
Search for other papers by Savi R Shishkov in
Google Scholar
PubMed
Università “Federico II” di Napoli, Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Naples, Italy
Search for other papers by Luigi Tuccillo in
Google Scholar
PubMed
Search for other papers by Violeta M Iotova in
Google Scholar
PubMed
Search for other papers by Rosario Pivonello in
Google Scholar
PubMed
Search for other papers by Iris CM Pelsma in
Google Scholar
PubMed
Department of Endocrinology and Metabolism, Amsterdam Gastroenterology Endocrinology & Metabolism, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, Netherlands
Search for other papers by Alberto M Pereira in
Google Scholar
PubMed
Adult Chair of MTG Pituitary of Endo-ERN
Search for other papers by Nienke R Biermasz in
Google Scholar
PubMed
Search for other papers by the Endo-ERN Reference Centers of the Main Thematic Group: Hypothalamic and Pituitary Conditions, Endo-ERN Pituitary Transition of Care Study Group in
Google Scholar
PubMed
the responding physician regarding the final answers to be used for data analysis. Partial completions of the survey by one respondent were included in the study analysis due to the independent nature of the survey questions. Survey content The
Université Clermont Auvergne, Faculté de Médecine, Clermont-Ferrand, France
Search for other papers by Sylvain Roumeau in
Google Scholar
PubMed
Search for other papers by Joannice Thevenon in
Google Scholar
PubMed
CHU Clermont-Ferrand, Service de Biostatistiques, Clermont-Ferrand, France
Search for other papers by Lemlih Ouchchane in
Google Scholar
PubMed
CHU de Clermont-Ferrand, Service d’Endocrinologie, Diabétologie et Maladies Métaboliques, Clermont-Ferrand, France
Laboratoire GReD: UMR Université Clermont Auvergne-CNRS 6293, INSERM U1103, Clermont-Ferrand, France
Search for other papers by Salwan Maqdasy in
Google Scholar
PubMed
Laboratoire GReD: UMR Université Clermont Auvergne-CNRS 6293, INSERM U1103, Clermont-Ferrand, France
Search for other papers by Marie Batisse-Lignier in
Google Scholar
PubMed
CHU Clermont-Ferrand, Inserm CIC 1405, Clermont-Ferrand, France
Search for other papers by Christian Duale in
Google Scholar
PubMed
Université Clermont Auvergne, Inserm, Neuro-Dol, Clermont-Ferrand, France
CHU de Clermont-Ferrand, Service de chirurgie maxillo-faciale, Clermont-Ferrand, France
Search for other papers by Nathalie Pham Dang in
Google Scholar
PubMed
Search for other papers by Philippe Caron in
Google Scholar
PubMed
Université Clermont Auvergne, Faculté de Médecine, Clermont-Ferrand, France
Laboratoire GReD: UMR Université Clermont Auvergne-CNRS 6293, INSERM U1103, Clermont-Ferrand, France
Search for other papers by Igor Tauveron in
Google Scholar
PubMed
Université Clermont Auvergne, Inserm, Neuro-Dol, Clermont-Ferrand, France
Université Clermont Auvergne, Faculté de Chirurgie Dentaire, Clermont-Ferrand, France
Search for other papers by Laurent Devoize in
Google Scholar
PubMed
immunoassay (Immulite 2000, Siemens, Erlangen, Germany) and used to classify hormonal control according to current recommendations ( 14 ). All patients answered AcroQoL and EPICES auto-questionnaires. AcroQoL is a validated disease-specific questionnaire to
Search for other papers by Julie Wulf Christensen in
Google Scholar
PubMed
Search for other papers by Karin Folmer Thøgersen in
Google Scholar
PubMed
Search for other papers by Lars Thorbjørn Jensen in
Google Scholar
PubMed
Department of Clinical Physiology and Nuclear Medicine, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark
Search for other papers by Martin Krakauer in
Google Scholar
PubMed
Search for other papers by Bent Kristensen in
Google Scholar
PubMed
Search for other papers by Finn Noe Bennedbæk in
Google Scholar
PubMed
Search for other papers by Bo Zerahn in
Google Scholar
PubMed
COVID-19 lockdown, while the rest were included during the pandemic. There is no way of knowing the effects the lockdown may have had because the time point for answering the QoL questionnaires and surgery inevitably varied for each patient with respect
Search for other papers by Carla Scaroni in
Google Scholar
PubMed
Search for other papers by Nora M Albiger in
Google Scholar
PubMed
Search for other papers by Serena Palmieri in
Google Scholar
PubMed
Search for other papers by Davide Iacuaniello in
Google Scholar
PubMed
Search for other papers by Chiara Graziadio in
Google Scholar
PubMed
Search for other papers by Luca Damiani in
Google Scholar
PubMed
Search for other papers by Marialuisa Zilio in
Google Scholar
PubMed
Search for other papers by Antonio Stigliano in
Google Scholar
PubMed
Search for other papers by Annamaria Colao in
Google Scholar
PubMed
Search for other papers by Rosario Pivonello in
Google Scholar
PubMed
Search for other papers by the Altogether to Beat Cushing’s Syndrome (ABC) study group in
Google Scholar
PubMed
several drugs affect the dynamic test results. By describing and discussing a clinical case, this review attempts to answer some common questions that physicians may face in the clinical practice. Clinical case A 26-year-old female was referred
Search for other papers by Małgorzata Więcek in
Google Scholar
PubMed
Search for other papers by Jakub Gawlik in
Google Scholar
PubMed
Search for other papers by Zuzanna Nowak in
Google Scholar
PubMed
Search for other papers by Aneta Gawlik in
Google Scholar
PubMed
the FP procedures. Material and methods In our study, we set out to answer three questions important for successful preservation of fertility and safe pregnancy in TS. For each of those questions, separate literature searches have been
Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Georgios Kontogeorgos in
Google Scholar
PubMed
Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Zoi Mamasoula in
Google Scholar
PubMed
Department of Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Emily Krantz in
Google Scholar
PubMed
Section for Endocrinology, Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Penelope Trimpou in
Google Scholar
PubMed
Section for Endocrinology, Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Kerstin Landin-Wilhelmsen in
Google Scholar
PubMed
Endocrine Out-Patient Clinic, Carlanderska Hospital, Gothenburg, Sweden
Search for other papers by Christine M Laine in
Google Scholar
PubMed
, n = 414. Of the 203 patients with chronic HypoPT who met the diagnostic criteria above, 164 were alive in 2020 and 106 answered the HRQoL questionnaires, yielding a participation rate of 65%. Height, weight, x-ray results, medications and drug